BLUEVOYANT LLC – Trademark Portfolio
Entity Type: 16
BLUEVOYANT LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BLUEVOYANT. The owner is based in NEW YORK, NY.
335 MADISON AVENUE
SUITE 5G
NEW YORK, NY 10017
Showing of trademarks Trademarks
Trademark Classifications
BLUEVOYANT LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does BLUEVOYANT LLC have?
BLUEVOYANT LLC has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 cancelled.
What trademark classes does BLUEVOYANT LLC file in?
BLUEVOYANT LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 45 (Legal & Security Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are BLUEVOYANT LLC's most well-known trademarks?
BLUEVOYANT LLC's registered trademark portfolio includes well-known marks such as BLUEVOYANT. These are among 1 currently registered trademark in the portfolio.
What is BLUEVOYANT LLC's trademark registration success rate?
BLUEVOYANT LLC has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.